Traws Pharma Files 8-K Reporting Earnings Release (Aug 14, 2026)

What Happened
Traws Pharma, Inc. (TRAW) filed a Form 8-K on August 14, 2026 to report results of operations and financial condition by furnishing an earnings press release. The company also made a Regulation FD disclosure referencing that same earnings release and incorporated the release by reference into the Form 8-K.

Key Details

• Filing date: August 14, 2026 (Form 8-K).
• Items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibit included: 99.1 — Press Release dated August 14, 2026 (and 104 — Cover Page Interactive Data File).
• The earnings release is incorporated by reference into the Form 8-K; investors should review the press release for the company’s reported financial figures and other specifics.

Why It Matters
This filing notifies investors that Traws Pharma publicly released its latest earnings/financial results and followed Regulation FD procedures to ensure broad, fair disclosure. Retail investors should read the attached press release (Exhibit 99.1) to see the company’s revenue, earnings, or other material financial metrics and any commentary management provided.